-
FDA approves Par's generic bupropion hydrochloride extended-release tablets
WOODCLIFF LAKE, N.J. — The Food and Drug Administration has approved a generic drug for depression made by Par Pharmaceutical Cos., the drug maker said Tuesday.
Par announced the approval of bupropion hydrochloride extended-release tablets in the 300-mg strength. The drug is a generic version of GlaxoSmithKline's Wellbutrin XL and is used to treat major depressive disorder. The company already markets the generic drug in the 150-mg strength.
-
Carex launches bathroom safety mat featuring foot scrubbers and pumice stone
NORWELL, Mass. — Carex Health Brands last week launched a new bathroom mat to its lineup of bathroom safety products.
The Carex Deluxe Bath Mat (B222-00) provides a slip-resistant surface for bathing or showering with hundreds of suction cups that anchor the bath mat to the bottom of the tub.